-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on BrightSpring Health, Raises Price Target to $92

Benzinga·11/02/2026 21:33:06
Listen to the news
UBS analyst A.J. Rice maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the price target from $85 to $92.